Key result
Nedd4L regulates epithelial sodium channel activity and participates in the pathophysiology of hypertension, cardiomyopathy, and heart failure, highlighting its potential as a therapeutic target.
Why the study?
The role of the ubiquitin ligase Nedd4L in the cardiovascular field is not fully understood.
Answers are grounded in this paper and cite their sources.
Targeting the ubiquitin ligase Nedd4L and its related pathways may provide a potential novel therapeutic approach for the prevention and treatment of various cardiovascular diseases.
Post-translational modifications (PTMs) are a covalent processing process of proteins after translation. Proteins are capable of playing their roles only after being modified, so as to maintain the normal physiological function of cells. As a key modification of protein post-translational modification, ubiquitination is an essential element, which forms an enzyme-linked reaction through ubiquitin-activating enzyme, ubiquitin binding enzyme, and ubiquitin ligase, aiming to regulate the expression level and function of cellular proteins. Nedd4 family is the largest group of ubiquitin ligases, including 9 members, such as Nedd4-1, Nedd4L (Nedd4-2), WWP1, WWP2, ITCH, etc. They could bind to substrate proteins through their WW domain and play a dominant role in the ubiquitination process, and then participate in various pathophysiological processes of cardiovascular diseases (such as hypertension, myocardial hypertrophy, heart failure, etc.). At present, the role of Nedd4L in the cardiovascular field is not fully understood. This review aims to summarize the progress and mechanism of Nedd4L in cardiovascular diseases, and provide potential perspective for the clinical treatment or prevention of related cardiovascular diseases by targeting Nedd4L.
No takes yet. Share an insight, caveat, or question.
Li et al. (2022) conducted a review in Cardiovascular diseases (hypertension, cardiomyopathy, heart failure, arrhythmias). Nedd4L was evaluated. Nedd4L regulates epithelial sodium channel activity and participates in the pathophysiology of hypertension, cardiomyopathy, and heart failure, highlighting its potential as a therapeutic target.
Synapse has enriched 10 related papers. Consider them for comparative context: